About Meridian Bioscience
Meridian Bioscience is a company based in United States founded in 1976 was acquired by SJL Partners in July 2022. Meridian Bioscience has completed 5 acquisitions, including Bioline, Exalenz Bioscience and GenePOC Diagnostics. Meridian Bioscience operates in a competitive market with competitors including Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Teknova, among others.
- Headquarter Ohio, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Meridian Bioscience Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$5.5 M (USD), Grant
Feb 03, 2021
-
Investors
NIH
& 3 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Bioline
& 4 more
-
Acquired by
SJL Partners
(Jul 07, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Meridian Bioscience
Unlock access to complete
Unlock access to complete
Software Development Team
29 people
Sales and Marketing
21 people
Leadership Team
14 people
Product Management Team
13 people
Finance and Accounting
9 people
Senior Team
7 people
Manager Team
6 people
Human Resources and Administration
5 people
Unlock access to complete
Funding Insights of Meridian Bioscience
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $5.5M
-
First Round
First Round
(16 Dec 2020)
- Investors Count 2
Investors in Meridian Bioscience
Meridian Bioscience has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, SD Biosensor and JobsOhio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Cross-border investments are managed by SJL Partners in key regions.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location | |
|
JobsOhio is focused on economic development in Ohio.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Meridian Bioscience
Meridian Bioscience has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Bioline, Exalenz Bioscience and GenePOC Diagnostics.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Point-of-care nucleic acid assays for infectious diseases are developed rapidly.
|
2007 | ||||
|
Breath gas analysis to detect H pylori infection and diagnose Gastric and hepatocellular cancer
|
2006 | ||||
|
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
|
1997 |
Financial Statements - Meridian Bioscience
Meridian Bioscience Comparisons
Competitors of Meridian Bioscience
Meridian Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, OriGene, Sangon Biotech and Teknova, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological reagents and antibodies are developed for life science research.
|
|
| domain | founded_year | HQ Location |
Developer of cell culture media and ancillary reagents for life science research
|
|
| domain | founded_year | HQ Location |
Proteins, antibodies, and molecular tools are manufactured for research applications.
|
|
| domain | founded_year | HQ Location |
Research services, reagents, and kits for biotech applications are provided.
|
|
| domain | founded_year | HQ Location |
Molecular biology reagents and kits are supplied for research applications.
|
Latest news on Meridian Bioscience
Frequently Asked Questions about Meridian Bioscience
Meridian Bioscience was founded in 1976 and raised its 1st funding round 44 years after it was founded.
Meridian Bioscience is headquartered in United States. It is registered at Ohio, United States.
Jack Kenny is the current CEO of Meridian Bioscience.
Meridian Bioscience, is a life science company that develops, manufactures, markets, and distributes a broad range of diagnostic test kits for infectious diseases, purified reagents, and related products and offers biopharmaceutical enabling technologies. The companys proprietary product illumigene is a portable molecular diagnostic system that allows the detection of C. difficile, GroupA B Streptococcus, HSV 1 2 Mycoplasma, and Pertussis. In addition, Meridian is a supplier of rare reagents, specialty biologicals, and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines.
Meridian Bioscience's top competitors include Abcam, Stem Cell Technologies and Cayman Chem.
Meridian Bioscience has made 5 acquisitions, including Bioline, Exalenz Bioscience, and GenePOC Diagnostics.
Meridian Bioscience has 4 investors. Key investors include NIH, SD Biosensor, JobsOhio, and SJL Partners.